Patients with non-small cell lung cancer and resistance to gefitinib do not experience any significant improvement with gefitinib.
Certain conditions make it harder to reliably detect tumors, and regions with locally-endemic infectious lung diseases pose an added hurdle for lung cancer detection.
Patients who undergo traditional surgery for the treatment of early stage non-small cell lung cancer fare better in the long-term.
The addition of chest radiation reduces recurrence rate and, improves survival when added to chemo in extensive stage small-cell lung cancer.
Advanced small cell lung cancer patients experienced prolonged survivalafter being treated prophylactic cranial radiotherapy.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|